Category: Alzheimers

Enhancing Lives Through Knowledge: Our New Dementia Collection

We are thrilled to announce the addition of a comprehensive Dementia Collection to our library! This new resource is designed to support individuals, families, and caregivers who are navigating the challenges of dementia.

What You Can Find in Our Dementia Collection:

Educational Books and Guides: Learn about the latest research, treatment options, and caregiving strategies from leading experts in the field.

Personal Stories and Memoirs: Gain insight and empathy through the experiences of those living with dementia and their loved ones.

Activity Resources: Discover activities and programs tailored to engage and support cognitive function for individuals with dementia.

Support Resources for Caregivers: Find practical advice and emotional support to help caregivers manage their responsibilities and well-being.

Visit our library today and start discovering these vital resources. Together, we can make a difference in the lives of those touched by dementia.

Library Bulletins

Dementia

The current bulletin for Dementia, produced by Merseycare NHS Foundation Trust, is now available to view and download.

For support accessing any of the articles within the bulletins please contact: academic.library@lscft.nhs.uk

Depression

The current bulletin for Depression, produced by Merseycare NHS Foundation Trust, is now available to view and download.

For support accessing any of the articles within the bulletin please contact: academic.library@lscft.nhs.uk

Assessing the Preparedness of the Health Care System Infrastructure in Six European Countries for an Alzheimer’s Treatment

RAND Corporation, October 2018
This research analyzes the preparedness of the health care systems in six European countries — France, Germany, Italy, Spain, Sweden, and the United Kingdom — to ensure timely diagnosis and treatment of patients if a disease-modifying therapy for Alzheimer’s becomes available. It finds:

  • The burden of Alzheimer’s disease in high-income countries is expected to approximately double between 2015 and 2050. Recent clinical trial results give hope that a disease-modifying therapy might become available in the near future. The therapy is expected to treat early-stage patients to prevent or delay the progression to dementia.
  • This preventive treatment paradigm implies the need to screen, diagnose, and treat a large population of patients with mild cognitive impairment. There would be many undiagnosed prevalent cases that would need to be addressed initially, and then the longer-term capacity to address incident cases would not need to be as high.
  • We use a simulation model to assess the preparedness of the health care system infrastructure in six European countries — France, Germany, Italy, Spain, Sweden, and the United Kingdom — to evaluate, diagnose, and treat the expected number of patients.
  • Projected peak wait times range from five months for treatment in Germany to 19 months for evaluation in France. The first year without wait times would be 2030 in Germany and 2033 in France, and 2042 in the United Kingdom and 2044 in Spain. Specialist capacity is the rate-limiting factor in France, the United Kingdom, and Spain, and treatment delivery capacity is an issue in most of the countries.
  • If a disease-modifying therapy becomes available in 2020, we estimate the projected capacity constraints could result in over 1 million patients with mild cognitive impairment progressing to Alzheimer’s dementia while on wait lists between 2020 and 2050 in these six countries.

Click here to view the full report.